Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07154394

Cardiac Amyloid Deposits and Heart Dysfunction in Alzheimer's Disease

Investigation of Cardiac Amyloid Deposits as a Cause of Cardiac Dysfunction in Alzheimer's Disease (Untersuchung Von Kardialen Amyloidablagerungen Als Ursache Einer Funktionseinschränkung Des Herzens Bei Alzheimer Demenz)

Status
Recruiting
Phase
Study type
Observational
Enrollment
15 (estimated)
Sponsor
University Hospital, Essen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study seeks to explore the possible common pathogenesis of both cardiac amyloidosis and Alzheimer's disease, which can both be associated with amyloid deposits. Using Positron Emission Tomography (PET) scans with amyloid tracers - a conventional tool for non-invasively imaging amyloid deposits in Alzheimer's disease - the research will extend this imaging methodology to the heart. The study will conduct additional PET/MRI scans of the heart in patients undergoing amyloid tracer PET scans for Alzheimer's evaluations. Each participant will also undergo an echocardiogram and a clinical examination of dementia. This could potentially enhance diagnostic practices in both cardiac amyloidosis and Alzheimer's disease.

Conditions

Timeline

Start date
2022-08-15
Primary completion
2023-08-14
Completion
2025-09-14
First posted
2025-09-04
Last updated
2025-09-04

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT07154394. Inclusion in this directory is not an endorsement.